These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1970536

  • 1. The effect of xamoterol in failing human myocardium.
    Schwinger RH, Böhm M, Erdmann E.
    Eur Heart J; 1990 Apr; 11(4):323-7. PubMed ID: 1970536
    [Abstract] [Full Text] [Related]

  • 2. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
    Böhm M, Mittmann C, Schwinger RH, Erdmann E.
    Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium.
    Deighton NM, Motomura S, Bals S, Zerkowski HR, Brodde OE.
    J Pharmacol Exp Ther; 1992 Aug; 262(2):532-8. PubMed ID: 1354251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
    Pouleur H, Hanet C, Rousseau MF.
    Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Xamoterol activates beta 1- but not beta 2-adrenoceptors in mammalian myocardium: comparison of its affinity for beta 1- and beta 2-adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects.
    Lemoine H, Bilski A, Kaumann AJ.
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):105-17. PubMed ID: 2468921
    [Abstract] [Full Text] [Related]

  • 10. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
    Maack C, Böhm M, Vlaskin L, Dabew E, Lorenz K, Schäfers HJ, Lohse MJ, Engelhardt S.
    Circulation; 2003 Jul 22; 108(3):348-53. PubMed ID: 12847069
    [Abstract] [Full Text] [Related]

  • 11. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK.
    Clin Cardiol; 1990 Mar 22; 13(3):171-6. PubMed ID: 1969783
    [Abstract] [Full Text] [Related]

  • 12. Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.
    Yabana H, Watanabe H, Narita H, Nagao T.
    Br J Pharmacol; 1992 Jun 22; 106(2):335-41. PubMed ID: 1356559
    [Abstract] [Full Text] [Related]

  • 13. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
    Nuttall A, Snow HM.
    Br J Pharmacol; 1982 Oct 22; 77(2):381-8. PubMed ID: 6128041
    [Abstract] [Full Text] [Related]

  • 14. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.
    Schwinger RH, Böhm M, Müller-Ehmsen J, Uhlmann R, Schmidt U, Stäblein A, Uberfuhr P, Kreuzer E, Reichart B, Eissner HJ.
    Circulation; 1993 Nov 22; 88(5 Pt 1):2267-76. PubMed ID: 8222121
    [Abstract] [Full Text] [Related]

  • 15. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
    Snow HM.
    Br J Clin Pharmacol; 1989 Nov 22; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
    [Abstract] [Full Text] [Related]

  • 16. Long-term studies with xamoterol in heart failure.
    Waller DG.
    Br J Clin Pharmacol; 1989 Nov 22; 28 Suppl 1(Suppl 1):53S-58S. PubMed ID: 2572255
    [Abstract] [Full Text] [Related]

  • 17. The in vitro pharmacology of xamoterol (ICI 118,587).
    Malta E, Mian MA, Raper C.
    Br J Pharmacol; 1985 May 22; 85(1):179-87. PubMed ID: 2862938
    [Abstract] [Full Text] [Related]

  • 18. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
    Böhm M, Diet F, Feiler G, Kemkes B, Kreuzer E, Weinhold C, Erdmann E.
    J Cardiovasc Pharmacol; 1988 Dec 22; 12(6):726-32. PubMed ID: 2467092
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y, Sakuma I, Nakao Y, Kanno M.
    J Pharmacol Exp Ther; 1987 Sep 22; 242(3):1077-85. PubMed ID: 2888870
    [Abstract] [Full Text] [Related]

  • 20. Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
    Böhm M, Pieske B, Schnabel P, Schwinger R, Kemkes B, Klövekorn WP, Erdmann E.
    J Cardiovasc Pharmacol; 1989 Oct 22; 14(4):549-59. PubMed ID: 2478768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.